Experimental evidences suggest that inhibition of CTSS attenuates the progression of atherosclerosis during chronic kidney disease [84], improves sugar levels during type2 diabetes [208], and prevents autoantigen presentation and autoimmunity [229]. Here, CTSS is linked to atherosclerosis.